Back to Journals » Risk Management and Healthcare Policy » Volume 18

Healthcare Professionals’ Knowledge and Attitudes Toward Antimicrobial Stewardship Programs in Aseer, Saudi Arabia: A Cross-Sectional Study

Authors Bahamdan AK, Alavudeen SS , Bahamdan GK, Bahamdan KA, Asiri SMA, Alshahrani NAM, Abdulziz Alqahtani S, Ibrahim ARN

Received 4 December 2024

Accepted for publication 3 March 2025

Published 12 March 2025 Volume 2025:18 Pages 855—867

DOI https://doi.org/10.2147/RMHP.S507235

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Gulsum Kubra Kaya



Ahmed Khaled Bahamdan,1 Sirajudeen Shaik Alavudeen,2 Ghadah Khaled Bahamdan,3 Khaled Ahmed Bahamdan,4 Saud Mohammed Ali Asiri,5 Nawaf Amer Mohammed Alshahrani,5 Saud Abdulziz Alqahtani,5 Ahmed RN Ibrahim2

1Pharmacy Training Unit, College of Pharmacy, King Khalid University, Abha, Saudi Arabia; 2Clinical Pharmacy Department, College of Pharmacy, King Khalid University, Abha, Saudi Arabia; 3Periodontics and Community Dental Sciences Department, College of Dentistry, King Khalid University, Abha, Saudi Arabia; 4Internal Medicine Department, College of Medicine, King Khalid University, Abha, Saudi Arabia; 5College of Pharmacy, King Khalid University, Abha, Saudi Arabia

Correspondence: Sirajudeen Shaik Alavudeen, Clinical Pharmacy Department, College of Pharmacy, King Khalid University, P.O. Box 960, Abha, 61421, Saudi Arabia, Email [email protected]

Background: Antimicrobial stewardship programs (ASPs) are initiatives designed to reduce the spread of antimicrobial resistance (AMR). ASPs enhance antimicrobial use, prevent errors, maintain guidelines, and monitor usage to reduce AMR.
Objective: This study aims to shed light on healthcare professionals’ (HCPs) knowledge, experience, and attitudes regarding ASPs.
Methods: This quantitative cross-sectional study, approved by the Research Ethics Committee at King Khalid University (ECM#2022-2023) was conducted in the Aseer region, Saudi Arabia. A validated self-administered online survey was distributed through various social media channels using snowball sampling between September 2022 and June 2024. The data from the online survey was analyzed using IBM SPSS Statistics.
Results: The sample included 388 participants. Just over half (53.1%) were male, and the remainder (46.9%) were female. Although a slight majority (54.9%) reported familiarity with ASPs, a professional practice gap was found; only 143 (36.9%) of the participants had direct experience working with such programs, while 64.7% reported inadequate training opportunities as a barrier to effective ASP implementation followed by lack of resources, lack of internal policies and guidelines, time constraints and lack of manpower (54.1%, 52.1%, 48.2% and 45.9%, respectively). Despite the high level of awareness across both genders and all HCPs, only half of the participants correctly identified that cutting antibiotic costs is not the primary goal of ASPs. There were significant differences among participants’ views toward repeated education and online resources (p = 0.042 and p = 0.024, respectively).
Conclusion: While HCPs have a good understanding of AMR, a professional practice gap was found. Thus, the study recommends offering ongoing education and training programs for HCPs. Addressing implementation obstacles, such as resource limitations and unclear guidelines, is also essential.

Keywords: antimicrobial resistance, antimicrobial usage optimization, antimicrobial stewardship, implementation barriers

Introduction

Antimicrobial agents are used to fight against infectious diseases and have saved millions of lives worldwide. The ability of microorganisms to withstand previously effective antimicrobial agents is defined as antimicrobial resistance (AMR).1 AMR is a critical global issue2–14 and causes over 23,000 deaths annually.6,9 Some studies project that this mortality rate could reach over 10 million by 2050.11,15 Although AMR develops naturally, it is accelerated by the misuse of antimicrobials in healthcare, agriculture, and aquaculture.1,3,7,9,12,13,16,17 Inappropriate use of antibiotics and widespread AMR raise concerns that antimicrobials may lose their sensitivity to a range of microorganisms.18

Antimicrobial stewardship programs (ASPs) aim to reduce AMR.19 Typically, a multidisciplinary team within a healthcare institution directs an ASP to ensure patient safety and promote optimum antimicrobial treatment by selecting the proper antibiotics and their dosage and length of treatment.20 The ASP team may consist of a variety of healthcare professionals (HCPs), including physicians, pharmacists, infection control specialists, microbiologists, nurses, allied health professionals, insurers, researchers, and government representatives.20

ASP implementations in Saudi Arabia is in the initial phase and more mandates more attention to make awareness towards rational antibiotic use in this country, with various regions in the country showcasing unique approaches to advance their antimicrobial stewardship programs. While Riyadh has historically been at the forefront of ASP initiatives, other regions in this country have also made significant strides in recent years.21

Although ASP guidelines, methods, and policies have been clearly defined by global19 and national organizations, such as the National Health Service22 and the Centers for Disease Control and Prevention,23 studies have revealed lacking implementation of ASPs.24–26 Another study claims that Middle Eastern and Gulf countries’ ASPs are underperforming due to a lack of clear guidelines.27,28 Baraka et al conducted a valuable review of ASP knowledge among HCPs in Saudi Arabia’s eastern region and discovered lacking of information about ASPs is one of the challenges preventing their implementation.29

The Saudi Arabian Ministry of Health (MOH) established a national ASP strategy in 2014 as part of the Arabian Gulf’s strategy to minimize the risk of AMR.26,27 Nonetheless, as Alghamdi et al have noted, despite efforts to reduce AMR, ASP implementation remains uncommon due to a lack of ASP knowledge and teams in Saudi hospitals.26 Some studies claim that a lack of current information on ASPs hinders HCPs from adopting them.24,29 More data should be collected to maximize the chances of ASP implementation success.25

Recent technological advancements have the potential to improve global ASP efforts significantly. Artificial intelligence (AI), for example, enhances the instant diagnosis of resistant bacteria by utilizing contemporary diagnostic techniques such as Kirby-Bauer disc diffusion and whole-genome sequencing. Moreover, AI can also help optimize pharmaceutical combinations, as proven by the enhanced efficacy of meropenem and polymyxin B against resistant bacteria.30 Recognizing the potential of these technologies, the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) actively support using advanced data analytics and artificial intelligence in public health. Given the benefits of these technologies, they could be leveraged to boost ASPs.31 Such applications may aid in optimizing antibiotic use and tracking resistance developments. To guarantee responsible implementation, the WHO has established regulatory frameworks such as transparency, data validation, cybersecurity, and data protection. These principles emphasize collaboration among regulators, healthcare experts, patients, industry, and governments to ensure that AI technology meets ethical norms and regulatory compliance.31

In Saudi Arabia, there is a dearth of literature on ASP awareness and perceptions among HCPs, especially regarding pharmacists in the Aseer region. It is evident that the involvement of all stakeholders in ASPs is vital, and their engagement in healthcare systems can help reduce inappropriate antibiotic usage.20,32 Despite HCPs’ knowledge of AMR, their awareness and practice of ASPs is limited.24,33,34 Therefore, this study aims to assess HCPs’ knowledge, awareness, and practice of ASPs in the Aseer region of Saudi Arabia, considering the perceived barriers, learning and training needs, and level of implementation.

Materials and Methods

Study Design and Site

This study employed a quantitative cross-sectional design. The data was collected between September 2022 and June 2024 using an anonymous online self-administered survey that was disseminated to various HCPs via social network platforms including WhatsApp, Telegram, and LinkedIn. Both male and female Saudi and non-Saudi HCPs were included in the study. We excluded healthcare students and interns as well as those outside the Aseer region.

Sample Size and Sampling Method

In 2023, the Saudi MOH estimated that the Aseer region had approximately 18,862 HCPs.35 The OpenEpi website was used to calculate the sample size needed for this study.36 To obtain a 95% confidence interval with a 5% margin of error, the minimum required number of participants was found to be 377. We used the snowball sampling technique to recruit participants for the study.

Survey Development and Validation

The survey was created by adapting questions from a relevant study published earlier and the draft survey was validated.29 To ensure its validity, two experts from King Khalid University’s Department of Clinical Pharmacy independently assessed the relevance of each question to the study’s objectives and provided feedback. Adjustments were then made based on their evaluations. Next, the initial survey was pilot-tested with 16 participants who met the inclusion criteria to confirm the clarity of the questions. Feedback from these respondents prompted further revisions. The data collected during the pilot test was not included in the final results or analysis.

The final survey consisted of five sections. The first section collected sociodemographic data. The second section determined whether the respondents had prior participation and expertise in ASPs. The third section included questions related to the presence and implementation of specific ASP policies in Aseer-region hospitals. The fourth section dealt with the identification of significant obstacles to ASP implementation. The last section survey assessed the HCPs’ perceptions and attitudes regarding ASPs.

Data Collection

The survey was administered online (Google Forms) using social media platforms, including WhatsApp and Telegram, to facilitate data collection. We employed the snowball sampling technique to collect the data. Initially, the survey was distributed to the HCPs in the authors’ circle, who were then asked to distribute the survey to their professional groups.

Data Analysis

The responses were exported from Google Forms to an Excel spreadsheet, cleaned and decoded, and then analyzed using IBM SPSS Statistics Version 29.0 for Mac. Descriptive statistics were used to analyze the demographic data and survey responses. A chi-squared test was used to compare the responses among the different healthcare professionals. A p-value of less than 0.05 was considered to indicate statistical significance.

Ethical Considerations

This study was approved by the Research Ethics Committee at King Khalid University (HAPO-06_B-001, ECM#2022-2023).

Results

Participant Characteristics

The demographics and professional backgrounds of the participants are summarized in Table 1. The study population consisted of 388 HCPs representing diverse cohorts of the medical community. The sample ages varied, with 37.4% being 30 years or younger, 39.4% between the ages of 31 and 40, and 23.2% aged 41 and above. Regarding nationality, about half of the participants (56.7%) were Saudi. Concerning profession, the majority were pharmacists (31.4%); physicians comprised 24.0% of the sample, followed by nurses at 19.1%. Pharmacy technicians accounted for 3.9%, dentists for 13.4%, allied medical scientists for 6.4%, and those in other healthcare-related fields for 1.8%. The Regarding gender, 53.1% were male, and 46.9% were female. The participants’ experience levels varied, with 35.1% having over 10 years of experience.

Table 1 Demographic Information of the Participants (n = 388)

Prior Participation and Expertise in AMR and ASPs

The participants’ prior knowledge of and engagement with AMR and ASPs are presented in Table 2. The respondents were asked to provide “Yes” or “No” answers to the corresponding questions. While more than half of the respondents (54.9%) were familiar with ASPs and their components, only 36.9% had actual working experience with them. A high percentage of respondent (80.2%) reported increased AMR infections during the previous five years, with 64.2% reporting they had treated or dealt with patients with an antibiotic-resistant infection. Only 29.1% had received specific training related to ASPs. Most respondents (64.7%) reported that their current institution had guidelines or policies for diagnosing and treating infectious diseases. When asked about experience with ASPs, 205 respondents (52.8%) affirmed having worked at an institution with an ASP, while 183 (47.2%) reported having no experience with such an institution.

Table 2 Participants’ Prior Participation and Expertise in Antimicrobial Resistance and Antimicrobial Stewardship Programs

Participant Knowledge of ASPs

The responses in Table 3 revealed a high knowledge level regarding the main aspects of ASPs. The vast majority of respondents (94.3%) believed that prescribers should specify the indication for antibiotic use on prescriptions. Similarly, 96.4% recognized that ASPs enhance individual patient care by ensuring appropriate antibiotic use. The survey also found that 93.3% of participants agreed seeking approval from an antibiotic stewardship team would enhance appropriate antibiotic prescriptions. Additionally, 91.5% of participants agreed that broad-spectrum antibiotic use exacerbates antibiotic resistance when more specific agents would suffice. Despite this high knowledge level, misconceptions existed, with 51% incorrectly identifying the primary goal of ASP as curtailing hospital antibiotic expenses. A relatively low percentage of participants (63.4%) correctly identified whether it was always better to over-prescribe than under-prescribe antibiotics. A higher percentage (85.8%) recognized that antimicrobials can trigger fatal allergic reactions. Nearly all respondents (94.1%) recognized that ASPs reduce AMR problems. Additionally, 92% of them agreed that ASPs would help reduce hospitalization. A vast majority (94.8%) recognized that correct dosage adjustments for children and adults are crucial. A lower percentage (69.8%) correctly answered as to whether a patient can stop taking antibiotics if symptoms improve before the full course of treatment is completed.

Table 3 Participants’ Knowledge Questions Regarding Antimicrobial Resistance and Antimicrobial Stewardship Programs

Participant Attitudes Toward ASPs

The attitudes of the HCPs toward ASPs were overwhelmingly positive. A substantial majority of respondents (85.1%) agreed that repeated education and training on ASPs by infectious disease experts would be beneficial. Moreover, 81.2% endorsed providing real-time feedback on proper antibiotic use from other staff members, and 78.1% considered hospital formularies based on efficacy, toxicity, and cost critical in antimicrobial selection. In addition, 85.3% of respondents advocated for the availability of online ASP resources and clinical guidelines as essential tools for improving stewardship practices. The details regarding the participants’ attitudes toward ASPs are provided in Table 4.

Table 4 Participants’ Attitude Toward Antimicrobial Stewardship Programs (Highest in Bold)

Perceived Barriers to ASPs

The participants widely agreed on several barriers to ASP implementation (Figure 1). The most commonly mentioned barriers included inadequate training opportunities (64.7%), a lack of specialized ASP information resources (54.1%), a lack of internal policies or guidelines (52.1%), time constraints (48.2%), and financial limitations (46.9%). In addition, approximately half of the respondents agreed that the management professionals of many institutions were unfamiliar with ASPs and that there was a lack of manpower (46.6% and 45.9%, respectively). Similarly, 54.1% of the respondents agreed that the lack of specialized ASP resources was a barrier to ASP implementation.

Figure 1 Perceived barriers to antimicrobial stewardship programs: (B1) Lack of internal policy/guidelines; (B2) Management is unfamiliar with ASPs; (B3) Lack of manpower; (B4) Lack of time, which identifies the time constraints faced by healthcare providers that can limit their ability to participate in and prioritize ASPs; (B5) Inadequate training opportunities; (B6) Financial issue or limited funding; (B7) Lack of specialized ASP information resources.

Participant Characteristics and Knowledge of ASPs

There were no significant differences across genders regarding knowledge of ASPs and their role in enhancing patient care, as shown in Table 5. However, significant differences were found among professions for certain items, including the belief that prescribers should specify the indication for an antibiotic in the prescription (p = 0.028) and the understanding of the global threat posed by AMR (p = 0.047). Other items, such as the beneficial effect of using more-specific antibiotics over broad-spectrum ones in reducing microbial resistance and the effectiveness of ASP in reducing hospitalization, showed significant differences among the professions (p = 0.001 and 0.008, respectively; Table 5).

Table 5 Baseline Characteristics of Participants’ Knowledge Regarding Antimicrobial Resistance and Antimicrobial Stewardship Programs

Participant Characteristics and Attitudes Toward ASPs

The participants had positive attitudes toward several aspects of ASPs, without significant differences across genders (Table 6). Most participants recognized the importance of repeated ASP education and training, with a significant difference across professions (p = 0.042) and pharmacists giving the strongest endorsement (88.5%). Participants also valued the availability of online ASP resources. However, there were significant differences among professions (p = 0.024), with physicians showing the highest support (90.3%; Table 6).

Table 6 Baseline Characteristics of Participants’ Attitudes Regarding Antimicrobial Resistance and Antimicrobial Stewardship Programs

Discussion

Enhancing HCPs’ knowledge and practice of ASPs can help curtail the frequency of antibiotic resistance and promote the responsible use of antibiotics.37 Hence, it is essential to understand HCPs’ current knowledge, attitudes, and practices regarding ASPs and their implementation. This study was conducted to assess these factors among HCPs in the southern region of Saudi Arabia. The study’s participants demonstrated reasonable knowledge of ASPs and were willing to implement them in their clinical settings, similar to other HCPs worldwide.38,39 A large proportion of our study participants also agreed that antibiotic resistance is a global problem, and that ASPs are a key strategy for containing it. It is a good sign that antibiotic resistance is perceived as a major health issue, as this is the first step in proper antibiotic use.40 However, the participants reported a number of barriers to the implementation of ASPs. When compared with a similar study conducted recently in Jordan, which evaluated HCPs’ practice of and attitudes toward ASPs,41 the current study provides a deeper understanding and broader insights into how HCPs understand and perceive ASPs in addition to the barriers they experience in implementing them.

Despite exhibiting sufficient knowledge on some aspects of ASPs, a significant number of the participants demonstrated a deficiency in knowledge regarding antibiotic prescription and favored over-prescription of antibiotics and stopping the antibiotic course early if symptoms improve. Some of the participants also had the notion that the main objective of antibiotic stewardship was to curtail the hospital’s antibiotic expenses. Over-prescription is an important health issue. Previous studies showed that restricting antibiotic use, a recommendation reinforced by ASPs, helps control potential antibiotic side effects and AMR.42,43 According to the Infectious Diseases Society of America, optimizing the indication, selection, dosing, route of administration, and duration of antimicrobial therapy is an important aspect of maximizing the clinical cure or prevention of infection.44 Multi-drug resistant microbial organisms—organisms that develop resistance to one or more of the antibiotics used to treat them—are another important concern.45 These organisms tend to develop multi-drug resistance (MDR) as a result of the improper use of antibiotics, including the selection, dose, route of administration, and duration.46

Nearly half of the participants in the current study were unfamiliar with ASPs and had not had previous experience with them. Moreover, nearly two-thirds of the study population had not attended any specific training related to ASPs and their implementation. The majority of our participants were in strong agreement that MDR can be addressed only by implementing ASPs. Many studies support this view, stating that ASPs play a major role in promoting appropriate antimicrobial use.47,48 We observed a highly positive attitude among our participants (85.1%) toward repeated education and training on ASPs from ASP experts. This finding is echoed by a previous study conducted among pharmacists, medical doctors, nurses, and medical laboratory scientists, which reported an improvement in knowledge on ASPs among those who received training (as demonstrated by the selection of appropriate and reduced empirical antibiotic prescriptions).38 Given this finding and the responses of our participants, it is arguable that familiarizing HCPs with ASPs and providing continuing ASP training from infectious disease experts can assure the successful implementation of ASPs at healthcare institutions.49

Unfortunately, a considerable number of our participants had no prior ASP experience, and only 29.1% had attended specialist ASP training. This might be because ASPs are still being introduced in Saudi Arabia, and many institutions have not yet accepted them.50 The majority of our respondents agreed that requiring prescribers to document indications for antibiotics is a vital strategy for implementing ASPs.

Based on the results of the current study, it is apparent that the participants had huge interest in electronic and online support to successfully overcome antibiotic resistance and implement ASPs. They showed positive attitudes toward improving the availability of online resources related to ASPs, obtaining an annual antibiogram electronically, receiving assistance from a computer application in the selection of individualized antibiotics based on patient characteristics, and providing easy access to data on pathogens and their antimicrobial susceptibility testing results. It has been reported by many studies that the failure to implement ASPs may be due to a lack of medical informatics resources, which results in limited timely information and an inability to monitor appropriate antimicrobial use and follow-up. Ensuring access to an information technology (IT) system for stewardship will greatly improve the quality of patient care.51 The time leading up to appropriate antimicrobial therapy has also been directly correlated with successful treatment (ie, a longer time before effective therapy leads to higher mortality).51,52 Therefore, ensuring access to information, such as on the microbiologic results of blood culture tests, and suitable antimicrobial agent selection would be highly beneficial. These results suggest that IT should be incorporated as a key component of ASPs to ensure their successful implementation. This aligns with a recent study conducted in Saudi Arabia highlighting the importance of interprofessional networks and collaborations among HCPs, such as on committee work and guideline composition, as facilitators for the implementation of ASPs.53

Hospital formularies are critical components of ASPs. Many of our study participants confirmed that rational antibiotic selection in the hospital formulary is a significant promoter of ASPs.50 The hospital formulary provides guidelines on the appropriate use of antibiotics, including dosing, indications, and therapy duration, helping to avoid over-prescription. Moreover, the formulary can serve as a resource for clinician education on the latest evidence regarding antibiotic use and resistance. A well-managed formulary can also support infection control initiatives by guiding the choice of antibiotics that minimize the spread of resistant organisms. Therefore, providing a structured formulary plays a vital role in enhancing the effectiveness of ASPs, ultimately improving patient outcomes and combating antibiotic resistance.

Despite finding favorable attitudes toward ASPs, the current study revealed several barriers to their implementation. Most of the HCPs stated that a lack of ASP education and training programs, ASP specialist staff, specialized ASP information resources, internal policy/guidelines, and time were the most common barriers to ASP implementation, which aligns with previous findings.50,53 Specialist training opportunities are needed to successfully develop and implement ASPs and initiate appropriate steps for the management of infectious diseases.50 A lack of human resources, unfamiliarity with ASPs among management, and inadequate or limited funding were also reported as barriers to ASP implementation in the current study, supporting previous research findings.54–57

Limitations

This study’s specific focus on the Aseer region means its findings might not apply across all healthcare settings in Saudi Arabia, potentially limiting its broader applicability. Its cross-sectional design also means it does not capture changes over time, such as shifts in policies or practices. The results could also be prone to biases, such as inaccurate recall. Sample imbalance is another possible limitation. Pharmacists and physicians together accounted for over half (55.4%) of the participants, which may have led to results more reflective of their perspectives and with limited representation of views from other HCPs. In particular, pharmacy technicians and allied health professionals were underrepresented, at just 10.3% of the sample. This imbalance could also limit the study’s ability to fully grasp how ASPs are implemented across different healthcare roles and settings.

Conclusion

The findings demonstrate the substantial opportunities for improving the knowledge, experience and attitudes of ASPs among HCPs. Healthcare authorities and hospital management should take the initiative to provide periodical education programs and resources that address the knowledge gaps among HCPs and enhance ASP practices among HCPs. Furthermore, a rigorous effort is essential to overcome barriers to ASP implementation, including the establishment of clear guidelines, securing necessary manpower, and fostering more impactful response to this critical issue.

In light of these insights, we recommend initiating collaborative actions between healthcare institutions and professional organizations to develop and maintain a comprehensive database of ASP resources aimed at combating AMR and improving patient outcomes in Saudi Arabia.

Data Sharing Statement

The datasets are available from the corresponding author upon reasonable request.

Ethical Approval and Consent to Participate

Each participant signed a written informed consent form before enrolment. The survey was filled out anonymously, and the data was kept secret. There was no recognized danger to the trial subjects. Before the study began, the Research Ethics Committee of King Khalid University granted institutional ethical approval (E.C.M. #2022-2303).

Acknowledgment

The authors express their gratitude to King Khalid University, Saudi Arabia, for providing administrative and technical support.

Author Contributions

Each author significantly contributed to the project from its initial concept and study design to the actual execution and data collection. This included both conducting the analysis and interpreting the results. Furthermore, every author had a hand in either drafting or critically revising the manuscript. They also collectively agreed on the journal to which this article has been submitted. Every author reviewed and approved each version of the article before submission and during the revision process as well as the final version accepted for publication. Additionally, they agreed to any significant changes made during the proofing stage. All authors are committed to taking responsibility for the entire content of the article.

Funding

The authors extend their appreciation to the Deanship of Research and Graduate Studies at King Khalid University for funding this work through Large Research Project under grant number RGP2/391/45.

Disclosure

The authors report no conflicts of interest in this work.

References

1. Who.int. Available from: https://www.euro.who.int/data/assets/pdf_file/0005/348224/Fact-sheet-SDG-AMR-FINAL-07-09-2017. Accessed February 2, 2025.

2. Aggarwal R, Mahajan P, Pandiya S, et al. Antibiotic resistance: a global crisis, problems and solutions. Crit Rev Microbiol. 2024;50(5):896–921. doi:10.1080/1040841X.2024.2313024

3. Ahmed SK, Hussein S, Qurbani K, et al. Antimicrobial resistance: impacts, challenges, and future prospects. J Med Surg Public Health. 2024;2(100081):100081. doi:10.1016/j.glmedi.2024.100081

4. Hasan S, Al Zubaidi H, Saidawi W, Zitouni H, Hussein SA. Pharmacist insights into antimicrobial stewardship: a social marketing approach. Res Social Adm Pharm. 2024;20(2):190–202. doi:10.1016/j.sapharm.2023.11.003

5. Chaintarli K, Ingle SM, Bhattacharya A, Ashiru-Oredope D, Oliver I, Gobin M. Impact of a United Kingdom-wide campaign to tackle antimicrobial resistance on self-reported knowledge and behaviour change. BMC Public Health. 2016;16(1). doi:10.1186/s12889-016-3057-2

6. Inácio J, Barnes LM, Jeffs S, et al. Master of Pharmacy students’ knowledge and awareness of antibiotic use, resistance and stewardship. Curr Pharm Teach Learn. 2017;9(4):551–559. doi:10.1016/j.cptl.2017.03.021

7. Rather IA, Kim BC, Bajpai VK, Park YH. Self-medication and antibiotic resistance: crisis, current challenges, and prevention. Saudi J Biol Sci. 2017;24(4):808–812. doi:10.1016/j.sjbs.2017.01.004

8. Schrier L, Hadjipanayis A, Del Torso S, Stiris T, Emonts M, Dornbusch HJ. European Antibiotic Awareness Day 2017: training the next generation of health care professionals in antibiotic stewardship. Eur J Pediatr. 2018;177(2):279–283. doi:10.1007/s00431-017-3055-0

9. Milijasevic M, Veskovic-Moracanin S, Babic Milijasevic J, Petrovic J, Nastasijevic I. Antimicrobial resistance in aquaculture: risk mitigation within the one health context. Foods. 2024;13(15):2448. doi:10.3390/foods13152448

10. Gallagher JC, Justo JA, Chahine EB, et al. Preventing the post-antibiotic era by training future pharmacists as antimicrobial stewards. Am J Pharm Educ. 2018;82(6):6770. doi:10.5688/ajpe6770

11. Naghavi M, Vollset SE, Ikuta KS, et al. Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050. Lancet. 2024;404:1199–1226.

12. Ho CS, Wong CTH, Aung TT, et al. Antimicrobial resistance: a concise update. Lancet Microbe. 2024;6:100947. doi:10.1016/j.lanmic.2024.07.010

13. Van Katwyk R, Jones S, Hoffman SL. Mapping educational opportunities for healthcare workers on antimicrobial resistance and stewardship around the world. Hum Resour Health. 2018;16(1).

14. Rahman MM, Alam Tumpa MA, Zehravi M, et al. An overview of antimicrobial stewardship optimization: the use of antibiotics in humans and animals to prevent resistance. Antibiotics. 2022;11(5):667. doi:10.3390/antibiotics11050667

15. Garau J, Bassetti M. Role of pharmacists in antimicrobial stewardship programmes. Int J Clin Pharm. 2018;40(5):948–952. doi:10.1007/s11096-018-0675-z

16. Stanley D, Batacan R, Bajagai YS. Rapid growth of antimicrobial resistance: the role of agriculture in the problem and the solutions. Appl Microbiol Biotechnol. 2022;106(21):6953–6962. doi:10.1007/s00253-022-12193-6

17. Mason T, Trochez C, Thomas R, Babar M, Hesso I, Kayyali R. Knowledge and awareness of the general public and perception of pharmacists about antibiotic resistance. BMC Public Health. 2018;18(1). doi:10.1186/s12889-018-5614-3

18. Bertollo LG, Lutkemeyer DS, Levin AS. Are antimicrobial stewardship programs effective strategies for preventing antibiotic resistance? A systematic review. Am J Infect Control. 2018;46(7):824–836. doi:10.1016/j.ajic.2018.01.002

19. Villanueva P, Coffin SE, Mekasha A, Mcmullan B, Cotton MF, Bryant PA. Comparison of antimicrobial stewardship and infection prevention and control activities and resources between low-/middle-and high-income countries. Pediatr Infect Dis J. 2022;41(3S):S3–S9. doi:10.1097/INF.0000000000003318

20. Giamarellou H, Galani L, Karavasilis T, Ioannidis K, Karaiskos I. Antimicrobial stewardship in the hospital setting: a narrative review. Antibiotics. 2023;12(10):1557. doi:10.3390/antibiotics12101557

21. Haseeb A, Faidah HS, Al-Gethamy M, et al. Evaluation of Antimicrobial Stewardship Programs (ASPs) and their perceived level of success at Makkah region hospitals, Kingdom of Saudi Arabia. Saudi Pharm J. 2020;28(10):1166–1171. doi:10.1016/j.jsps.2020.08.005

22. Nhs.uk. Available from: https://www.leicspart.nhs.uk/wp-content/uploads/2021/10/Antimicrobial-Stewardship-Policy-exp-Oct-24.pdf. Accessed February 2, 2025.

23. Cdc.gov. Available from: https://www.cdc.gov/antibiotic-use/core-elements/hospital.html. Accessed February 2, 2025.

24. Rizvi T, Thompson A, Williams M, Zaidi STR. Perceptions and current practices of community pharmacists regarding antimicrobial stewardship in Tasmania. Int J Clin Pharm. 2018;40(5):1380–1387. doi:10.1007/s11096-018-0701-1

25. Maki G, Smith I, Paulin S, et al. Feasibility study of the World Health Organization health care facility-based antimicrobial stewardship toolkit for low- and middle-income countries. Antibiotics. 2020;9(9):556. doi:10.3390/antibiotics9090556

26. Alghamdi S, Berrou I, Aslanpour Z, et al. Antimicrobial stewardship programmes in Saudi hospitals: evidence from a national survey. Antibiotics. 2021;10(2):193. doi:10.3390/antibiotics10020193

27. Nasr ZG, Higazy A, Wilbur K. Exploring the gaps between education and pharmacy practice on antimicrobial stewardship: a qualitative study among pharmacists in Qatar. Adv Med Educ Pract. 2019;10:287–295. doi:10.2147/AMEP.S198343

28. Sharaf N, Al-Jayyousi GF, Radwan E, et al. Barriers of appropriate antibiotic prescription at PHCC in Qatar: perspective of physicians and pharmacists. Antibiotics. 2021;10(3):317. doi:10.3390/antibiotics10030317

29. Baraka MA, Alsultan H, Alsalman T, Alaithan H, Islam MA, Alasseri AA. Health care providers’ perceptions regarding antimicrobial stewardship programs (AMS) implementation-facilitators and challenges: a cross-sectional study in the Eastern province of Saudi Arabia. Ann Clin Microbiol Antimicrob. 2019;18(1):26. doi:10.1186/s12941-019-0325-x

30. Tran MH, Nguyen NQ, Pham HT. A New Hope in the fight against antimicrobial resistance with artificial intelligence. Infect Drug Resist. 2022;15:2685–2688. doi:10.2147/IDR.S362356

31. Pinto-de-Sá R, Sousa-Pinto B, Costa-de-Oliveira S. Brave new world of artificial intelligence: its use in antimicrobial stewardship-A systematic review. Antibiotics. 2024;13(4):307. doi:10.3390/antibiotics13040307

32. Alomi YA. National antimicrobial stewardship program in Saudi Arabia; Initiative and the future. Open Access J Surg. 2017;4(5). doi:10.19080/oajs.2017.04.555646

33. Akande-Sholabi W, Ajamu AT. Antimicrobial stewardship: assessment of knowledge, awareness of antimicrobial resistance and appropriate antibiotic use among healthcare students in a Nigerian University. BMC Med Educ. 2021;21(1):488. doi:10.1186/s12909-021-02912-4

34. Feng Z, Hayat K, Huang Z, et al. Knowledge, attitude, and practices of community pharmacy staff toward antimicrobial stewardship programs: a cross-sectional study from Northeastern China. Expert Rev Anti Infect Ther. 2021;19(4):529–536. doi:10.1080/14787210.2021.1826307

35. Statistical yearbook. Ministry of Health Saudi Arabia. Available from: https://www.moh.gov.sa/en/Ministry/Statistics/Book/Pages/default.aspx. Accessed February 2, 2025.

36. Openepi.com. Available from: https://www.openepi.com/SampleSize/SSPropor.htm. Accessed February 2, 2025.

37. Darwish RM, Baqain GN, Aladwan H, Salamah LM, Madi R. Knowledge, attitudes, and practices regarding antibiotic use and resistance among community pharmacists: a cross-sectional study in Jordan. Int J Clin Pharm. 2021;43(5):1198–1207.

38. Alqahtani NS, Bilal MM, Al Margan AM, Albaghrah FA, Al Sharyan AM, Alyami ASM. Assessment of physicians’ practice in implementing antibiotic stewardship program in Najran city, Saudi Arabia: a cross-sectional study. Pharmacy. 2024;12(1):24. doi:10.3390/pharmacy12010024

39. Alakhali KM, Alzomor A, Alavudeen S, Khan N, Dawbaa S. Bacterial resistance of antibiotics used in urinary tract infection. Asian J Pharm Clin Res. 2013;6(1):87–91.

40. Alavudeen SS, Vigneshwaran E, Asiri SAA, et al. Distribution of multi-resistant bacterial isolates from clinical specimens in a hospital environment of kingdom of Saudi Arabia. J Young Pharm. 2017;9(3):347–351. doi:10.5530/jyp.2017.9.69

41. Sutthiruk N, Considine J, Hutchinson A, Fry M. Antimicrobial stewardship for nurse practitioners. Am J Infect Control. 2018;46(12):1459–1462.

42. Khasawneh RA, Ababneh MA, Al-Azzam SI. Antimicrobial stewardship programs: perceptions and practices among Jordanian healthcare practitioners. J Pharm Health Serv Res. 2021;12(2):235–241. doi:10.1093/jphsr/rmaa034

43. Kpokiri EE, Ladva M, Dodoo CC, et al. Knowledge, awareness and practice with antimicrobial stewardship programmes among healthcare providers in a Ghanaian tertiary hospital. Antibiotics. 2021;11(1):6. doi:10.3390/antibiotics11010006

44. Miller JM, Binnicker MJ, Campbell S, et al. A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2018 update by the infectious diseases society of America and the American society for microbiology. Clin Infect Dis. 2018;67(6):813–816. doi:10.1093/cid/ciy584

45. Giurazza R, Mazza MC, Andini R, Sansone P, Pace MC, Durante-Mangoni E. Emerging treatment options for multi-drug-resistant bacterial infections. Life. 2021;11(6):519. doi:10.3390/life11060519

46. Antimicrobial resistance. Who.int. Available from: https://www.who.int/news-room/fact-sheets/detail/antibiotic-resistance. Accessed February 2, 2025.

47. Nwobodo C, Ugwu MC, Co A, Al-Ouqaili MT, Ikem JC, Chigozie UV. Antibiotic resistance: the challenges and some emerging strategies for tackling a global menace. J Clin Lab Anal. 2022;36(9).

48. Nasr Z, Babiker A, Elbasheer M, Osman A, Elazzazy S, Wilby KJ. Practice implications of an antimicrobial stewardship intervention in a tertiary care teaching hospital, Qatar. East Mediterr Health J. 2019;25(3):172–180. doi:10.26719/emhj.18.026

49. Suaifan G. A cross-sectional study on knowledge, attitude and behavior related to \ antibiotic use and resistance among medical and non-medical university students in Jordan. Afr J Pharm Pharmacol. 2012;6(10). doi:10.5897/ajpp12.080

50. Who.int. Available from: http://www.who.int/patientsafety/implementation/amr/publication/en/index.html. Accessed February 2, 2025.

51. Baraka MA, Alsultan H, Alsalman T, Alaithan H, Islam MA, Alasseri AA. Healthcare providers’ perceptions regarding antimicrobial stewardship programs (AMS) implementation-facilitators and challenges: a cross-sectional study in the Eastern Province of Saudi Arabia. Ann Clin Microbiol Antimicrob. 2019;18:1–10.

52. Evans RS, Olson JA, Stenehjem E, et al. Use of computer decision support in an antimicrobial stewardship program (ASP). Appl Clin Inform. 2015;6(1):120–135. doi:10.4338/ACI-2014-11-RA-0102

53. Kuper KM, Nagel JL, Kile JW, May LS, Lee FM. The role of electronic health record and ‘add-on’ clinical decision support systems to enhance antimicrobial stewardship programs. Infect Control Hosp Epidemiol. 2019;40(5):501–511. doi:10.1017/ice.2019.51

54. Alkhamees OA, Alnemer KA, Maneea B, Alsugair MW, Alenizi FA, Alharf BH. Top 10 most used drugs in the Kingdom of Saudi Arabia, 2010–2015. Saudi Pharm J. 2010;26:211–216.

55. Wong LH, Tay E, Heng ST, et al. Hospital pharmacists and antimicrobial stewardship: a qualitative analysis. Antibiotics. 2021;10(12):1441. doi:10.3390/antibiotics10121441

56. Sayegh N, Hallit S, Hallit R, Saleh N, Zeidan RK. Physicians’ attitudes on the implementation of an antimicrobial stewardship program in Lebanese hospitals. Pharm Pract. 2021;19(1):2192. doi:10.18549/PharmPract.2021.1.2192

57. Hayat K, Rosenthal M, Gillani AH, Zhai P, Aziz MM, Ji W. Perspectives of Pakistani physicians towards hospital antimicrobial stewardship programs: a multisite exploratory qualitative study. Int J Environ Res Public Health. 2019;16(9):1–15.

Creative Commons License © 2025 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, 3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.